We reiterate our HOLD rating on Ahold Delhaize but lower our target price from €36 to €35, as we reduce our top- and bottom-line forecasts on higher FX headwinds. We remain cautious on Ahold Delhaize USA's organic growth, noting the ongoing price investment programme while inflation starts to build, as highlighted by market leader Walmart in its 2Q release. Consensus continues to see flat underlying operating profit in the country (excl. FX), while we remain more cautious there. This leads us to...
NEWS SUMMARY: ENDESA. Markets maintain strong August performance Last week, stock markets closed with gains, with Chinese markets (CSI 300) and the FTSE 100 standing out. This performance was spurred at the end of the week by Powell’s comments in Jackson Hole in favour of rate cuts, admitting that the current, still restrictive monetary policy could be relaxed in view of the deteriorating job market. In the STOXX 600, the sectors that rose the most were defensive ones like Pharma, Utilities and...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ENDESA. EUROPA: ESSILORLUXOTTICA. Las bolsas mantienen el buen performance de agosto La semana pasada las bolsas cerraron con avances, destacando sobre todo los de la bolsa china (CSI 300) y el FTSE 100. Los índices se animaron hacia final de la semana tras unos comentarios a favor de recortes de tipos por parte de J. Powell en Jackson Hole al reconocer que la actual política monetaria todavía restrictiva podría relajarse ante el deterioro del merca...
A director at Intesa Sanpaolo S.p.A. sold 250,000 shares at 5.483EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
A director at Axa bought 2,000 shares at 41.728EUR and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Cl...
Ahold Delhaize reported a solid set of 2Q25 results, with comparable sales growth of 3.4% in the US (css: +3.1%) and +4.9% in the EU (css: +3.8%) exceeding expectations. While group margins contracted by 20bps to 4.0%, this was well anticipated on the back of ongoing price investments in the US and the dilutive impact from the consolidation of Profi in the EU. As such, the underlying group EBIT of € 917m came in slightly ahead of expectations (css: € 908m, css: € 905m). Following the solid 2Q25,...
ABN AMRO: Better bottom line, mixed underlying, strong capital, SBB €250m. Ahold Delhaize: 2Q25 profitability beat thanks to insurance results. Coca-Cola Europacific Partners PLC: Fizzing along nicely. Kinepolis: July 2025 box office in US/Canada and France down, on strong comps. Vonovia: Good results, 5.6% guidance increase. UCB: Evenity continues to surprise to the upside. Zabka: Another miss on Adj. Net Income in 2Q25
Rdos. 2T'25 vs 2T'24: Ventas: 23.092 M euros (+3,3% vs +2,8% BS(e) y +2,7% consenso); EBIT: 917,0 M euros (-1,7% vs -2,9% BS(e) y -2,7% consenso); BDI: 548,0 M euros (+9,8% vs +14,4% BS(e) y +14,2% consenso). Rdos. 1S'25 vs 1S'24: Ventas: 46.368 M euros (+5,2% vs +4,9% BS(e) y +4,9% consenso); EBIT: 1.807 M euros (+0,7% vs +0,1% BS(e) y +0,2% consenso);
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.